🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

David R. Fogelman

Merck & Co., Inc., Rahway, NJ, USA (United States)

ORCID: 0000-0002-4063-189X
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: Assessment of Clinical Response Following Atezolizumab and Bevacizumab Treatment in Patients With Neuroendocrine Tumors.

40 citations

Suyu Liu, Arvind Dasari, David R. Fogelman, Priya Bhosale, Armeen Mahvash +21 more

21 citations

Laura Prakash, Giuseppe Malleo, Andrea Caravati, Gauri R. Varadhachary, David R. Fogelman +13 more

6 citations

Clifton D. Fuller, Vivek Verma, W. Ian P. Mainwaring, Andres F. Espinoza, Austin B. Miller +10 more

41 citations

Jane E. Rogers, Kenneth R. Hess, Robert A. Wolff, Gauri R. Varadhachary, Milind Javle +7 more

0 citations

Thomas LaFramboise, Michael S. Lee, Cathy Eng, David R. Fogelman, Stanley R. Hamilton +14 more

41 citations

S. Greg Call, Helen J. Huang, A.L. Stuckett, Kiran Madwani, Abha Adat +16 more